Dilip Shanghvi | $10B+
Get in Touch with Dilip Shanghvi | Dilip Shanghvi is an Indian billionaire businessman, best known as the founder of Sun Pharmaceuticals, the largest pharmaceutical company in India and among the top generic drug makers in the world. His strategic vision and leadership have made significant impacts on the pharmaceutical industry globally.
Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman. Shanghvi is the founder of Sun Pharmaceuticals, a pharmaceutical company.[2][3] The Government of India awarded him the civilian honor of the Padma Shri in 2016.[4] India Today magazine ranked him 8th in India's most powerful people of 2017 list.[5] According to Forbes, as of May 2025, Shanghvi is the fifth richest person in India with an estimated net worth of US$28.9 billion.[6]
Dilip Shanghvi
Born1 October 1955 (age 69)
Amreli, Gujarat, India[1]
Alma materUniversity of Calcutta
Occupation(s)Founder and MD of Sun Pharmaceuticals
SpouseVibha Shanghvi
Children2
Contents
Early life
edit
Dilip Shanghvi was born in 1955 in a Jain family from Gujarat, India. [1] He was raised in Kolkata, where his father ran a small wholesale business trading generic medicines. Shanghvi studied at J. J. Ajmera High School. [7] and later earned a Bachelor of Commerce degree from the University of Calcutta. [8] During his early years, he helped his father manage the family’s pharmaceutical trading business, gaining firsthand experience of the industry. This background inspired him to start manufacturing his own medicines rather than just selling other companies’ products. [9]
Career
edit
After working in his father’s pharmaceutical distribution business in Kolkata, Dilip Shanghvi decided to start manufacturing his own medicines. In 1983, he founded Sun Pharmaceutical Industries with a small loan from his father, focusing initially on psychiatric drugs. The company began with a single manufacturing facility in Vapi,Gujarat. [10]
Sun Pharma steadily expanded its product range and market reach over the next decade. By 1993, profits had grown significantly, allowing Shanghvi to invest in dedicated research and development facilities. [11]
Under his leadership, Sun Pharma became known for its strategy of acquiring other companies to fuel growth. The most notable was the $4 billion acquisition of Ranbaxy Laboratories in 2014, which made Sun Pharma India’s largest pharmaceutical company and among the top global generic drug makers.[12]
Despite facing regulatory challenges and a drop in profits between 2014 and 2018, Shanghvi steered the company through recovery. By 2023, Sun Pharma reported profits exceeding ₹8,000 crore, with strong growth in its specialty medicines segment.[13]
Shanghvi has also overseen international acquisitions, including US-based Ocular Technologies in 2016 and Concert Pharmaceuticals in 2023, expanding Sun Pharma’s global footprint in specialty drugs. [14]
Community
edit
In January 2018, the Indian government appointed Shanghvi to the Reserve Bank of India's 21-member central board committee. He is chairman of the board of governors at IIT Bombay.[15] He was made a trustee of the Rhodes scholarship programme at Oxford University in 2017.[16]
Personal life
edit
Dilip Shanghvi was born into a Jain family and follows the Jain faith. [17] He is married to Vibha Shanghvi, and they have two children, Aalok and Vidhi. [18] Despite his wealth, Shanghvi is known for maintaining a low public profile and avoiding the limelight. and Aalok and a daughter, Vidhi, both of whom work for Sun Pharmaceuticals.[19]
Shanghvi is a devotee of Shrinathji and makes regular pilgrimage with his family to the deity's abode in the city of Nathdwara in Rajasthan. Photos and idols of the deity adore Sun Pharma's factory and offices.[20][21]
Book
edit
In 2019, journalist Soma Das authored The Reluctant Billionaire, the first and only biography of Dilip Shanghvi.[22] Published by Penguin Random House, the book was nominated for Tata Literature Award[23] in the Best Business Book category in November 2019.[24]
Business standard called the book "an excellent read" and suggested in a review that "Soma Das has been able to capture brilliantly the essence of Dilip Shanghvi"
Join UHNWI direct Affiliate Program
Earn Passive Income by Sharing Verified Contact Information of Billionaires, Centi-Millionaires, and Multi-Millionaires on the UHNWI Direct Platform
Maximize your earnings potential by sharing direct and validated contact information of the ultra-wealthy, including billionaires, centi-millionaires, and multi-millionaires. Join the UHNWI Direct platform and tap into a lucrative passive income stream by providing valuable data to those seeking high-net-worth connections. Start earning today with UHNWI Direct.
You may also be interested in reviewing other UHNWIs profiles.
To find the person you want to contact, start typing their name or other relevant tags in the search bar.
Please note: Our database contains over 10,000 direct contacts of UHNWIs, and it is highly likely that the individual you are seeking is already included. However, creating individual profiles for each contact is a meticulous and time-intensive process, So, if you are unable to find the profile of the individual you are looking for, please click here.
Filter by Net Worth: All | Billionaires | Centi-Millionaires | Multi-Millionaires
Filter by Location: All | USA | Canada | Europe | UK | Russia & CIS | Asia | MEIA | Australia | Latin America
Filter by Age: 1920-1930 | 1930-1940 | 1940-1950 | 1950-1960 | 1960-1970 | 1970-1980 | 1980-1990 | 1990-2000
Related People
UHNWI direct
